Reykjavik / Isafjordur, Iceland, June 17, 2013 – Kerecis Limited, the emerging tissue-regeneration company, today announced that Andri Sveinsson and Kristjan Johannesson have been appointed to the company’s board of directors.
Sveinsson, a partner at Novator Partners LLP in London, has extensive experience in banking and corporate finance. He has held board positions in listed and unlisted companies in several sectors, among these the generic pharmaceutical company Actavis.
Johannesson is an Isafjordur, Iceland-based professional. He is the chairman of Hradfrystihusid-Gunnvor hf., one of the largest companies in the Icelandic fish industry.
Comment:
Gudmundur Fertram Sigurjonsson, Founder and CEO, Kerecis:
“We welcome the new board members, whose skills and experience are particularly appropriate at this time in our development. Sveinsson has extensive corporate finance experience, and Johannesson strengthens our relationship with Icelandic investors as well as with the Icelandic manufacturing industry.”
